ARF-BP1/mule is a critical mediator of the ARF tumor suppressor

Cell

Volumn 121, Issue 7, 2005, Pages 1071-1083

  Chen, Delin ^a   Kon, Ning ^a   Li, Muyang ^a   Zhang, Wenzhu ^a   Qin, Jun ^b   Gu, Wei ^c  

^a Columbia University ^*  (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; PROTEIN MDM2; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; UBIQUITINATION; WILD TYPE;

EID: 21244451434     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2005.03.037     Document Type: Article

References (69)

1. L. Aravind The WWE domain: a common interaction module in protein ubiquitination and ADP ribosylation Trends Biochem. Sci. 26 2001 273 275
2. D. Bertwistle, M. Sugimoto, and C.J. Sherr Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23 Mol. Cell. Biol. 24 2004 985 996
3. S.D. Boyd, K.Y. Tsai, and T. Jacks An intact HDM2 RING-finger domain is required for nuclear exclusion of p53 Nat. Cell Biol. 2 2000 563 568
4. S.N. Brady, Y. Yu, L.B. Maggi Jr., and J.D. Weber ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway Mol. Cell. Biol. 24 2004 9327 9338
5. C.L. Brooks, and W. Gu Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation Curr. Opin. Cell Biol. 15 2003 164 171
6. A. Buchberger From UBA to UBX: new words in the ubiquitin vocabulary Trends Cell Biol. 12 2002 216 221
7. F. Bunz, A. Dutriaux, C. Lengauer, T. Waldman, S. Zhou, J.P. Brown, J.M. Sedivy, K.W. Kinzler, and B. Vogelstein Requirement for p53 and p21 to sustain G2 arrest after DNA damage Science 282 1998 1497 1501
8. J.M. Cummins, C. Rago, M. Kohli, K.W. Kinzler, C. Lengauer, and B. Vogelstein Tumour suppression: disruption of HAUSP gene stabilizes p53 Nature 428 2004 486 487
9. D. Dornan, I. Wertz, H. Shimizu, D. Arnott, G.D. Frantz, P. Dowd, K. O'Rourke, H. Koeppen, and V.M. Dixit The ubiquitin ligase COP1 is a critical negative regulator of p53 Nature 429 2004 86 92
10. S.M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 2001 494 498
11. B. Eymin, C. Leduc, J.L. Coll, E. Brambilla, and S. Gazzeri p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice Oncogene 22 2003 1822 1835
12. S. Fang, J.P. Jensen, R.L. Ludwig, K.H. Vousden, and A.M. Weissman Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53 J. Biol. Chem. 275 2000 8945 8951
13. D.A. Freedman, L. Wu, and A.J. Levine Functions of the MDM2 oncoprotein Cell. Mol. Life Sci. 55 1999 96 107
14. S.Y. Fuchs, V. Adler, T. Buschmann, X. Wu, and Z. Ronai Mdm2 association with p53 targets its ubiquitination Oncogene 17 1998 2543 2547
15. R.K. Geyer, Z.K. Yu, and C.G. Maki The MDM2 RING-finger domain is required to promote p53 nuclear export Nat. Cell Biol. 2 2000 569 573
16. A.J. Giaccia, and M.B. Kastan The complexity of p53 modulation: emerging patterns from divergent signals Genes Dev. 12 1998 2973 2983
17. J. Gu, K. Ren, R. Dubner, and M.J. Iadarola Cloning of a DNA binding protein that is a tyrosine kinase substrate and recognizes an upstream initiator-like sequence in the promoter of the preprodynorphin gene Brain Res. Mol. Brain Res. 24 1994 77 88
18. W. Gu, S. Malik, M. Ito, C.X. Yuan, J.D. Fondell, X. Zhang, E. Martinez, J. Qin, and R.G. Roeder A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation Mol. Cell 3 1999 97 108
19. Y. Haupt, R. Maya, A. Kazaz, and M. Oren Mdm2 promotes the rapid degradation of p53 Nature 387 1997 296 299
20. L. Hicke, and R. Dunn Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins Annu. Rev. Cell Dev. Biol. 19 2003 141 172
21. M. Hollstein, M. Hergenhahn, Q. Yang, H. Bartsch, Z.Q. Wang, and P. Hainaut New approaches to understanding p53 gene tumor mutation spectra Mutat. Res. 431 1999 199 209
22. R. Honda, and H. Yasuda Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53 EMBO J. 18 1999 22 27
23. R. Honda, H. Tanaka, and H. Yasuda Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 FEBS Lett. 420 1997 25 27
24. L. Huang, E. Kinnucan, G. Wang, S. Beaudenon, P.M. Howley, J.M. Huibregts, and N.P. Pavletich Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade Science 286 1999 1321 1326
25. K. Itahana, K.P. Bhat, A. Jin, Y. Itahana, D. Hawke, R. Kobayashi, and Y. Zhang Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation Mol. Cell 12 2003 1151 1164
26. S.N. Jones, A.E. Roe, L.A. Donehower, and A. Bradley Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 Nature 378 1995 206 208
27. T. Kamijo, F. Zindy, M.F. Roussel, D.E. Quelle, J.R. Downing, R.A. Ashmun, G. Grosveld, and C.J. Sherr Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF Cell 91 1997 649 659
28. T. Kamijo, J.D. Weber, G. Zambetti, F. Zindy, M.F. Roussel, and C.J. Sherr Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2 Proc. Natl. Acad. Sci. USA 95 1998 8292 8297
29. K.S. Kelly-Spratt, K.E. Gurley, Y. Yasui, and C.J. Kemp p19(Arf) suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and independent pathways PLoS Biol. 2 2004 e242, 10.1371/journal.pbio.0020242
30. C. Korgaonkar, L. Zhao, M. Modestou, and D.E. Quelle ARF function does not require p53 stabilization or Mdm2 relocalization Mol. Cell. Biol. 22 2002 196 206
31. C. Korgaonkar, J. Hagen, V. Tompkins, A.A. Frazier, C. Allamargot, F.W. Quelle, and D.E. Quelle Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function Mol. Cell. Biol. 25 2005 1258 1271
32. M.H. Kubbutat, S.N. Jones, and K.H. Vousden Regulation of p53 stability by Mdm2 Nature 387 1997 299 303
33. M.L. Kuo, E.J. Duncavage, R. Mathew, W. den Besten, D. Pei, D. Naeve, T. Yamamoto, C. Cheng, C.J. Sherr, and M.F. Roussel Arf induces p53-dependent and -independent antiproliferative genes Cancer Res. 63 2003 1046 1053
34. D.P. Lane Cancer. p53, guardian of the genome Nature 358 1992 15 16
35. R.P. Leng, Y. Lin, W. Ma, H. Wu, B. Lemmers, S. Chung, J.M. Parant, G. Lozano, R. Hakem, and S. Benchimol Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation Cell 112 2003 779 791
36. A.J. Levine p53, the cellular gatekeeper for growth and division Cell 88 1997 323 331
37. M. Li, C.L. Brooks, F. Wu-Baer, D. Chen, R. Baer, and W. Gu Mono- versus polyubiquitination: differential control of p53 fate by Mdm2 Science 302 2003 1972 1975
38. M. Li, C.L. Brooks, N. Kon, and W. Gu A dynamic role of HAUSP in the p53-Mdm2 pathway Mol. Cell 13 2004 879 886
39. A.W. Lin, and S.W. Lowe Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation Proc. Natl. Acad. Sci. USA 98 2001 5025 5030
40. S. Llanos, P.A. Clark, J. Rowe, and G. Peters Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus Nat. Cell Biol. 3 2001 445 452
41. S.W. Lowe, and C.J. Sherr Tumor suppression by Ink4a-Arf: progress and puzzles Curr. Opin. Genet. Dev. 13 2003 77 83
42. J. Luo, F. Su, D. Chen, A. Shiloh, and W. Gu Deacetylation of p53 modulates its effect on cell growth and apoptosis Nature 408 2000 377 381
43. R.N. McKeller, J.L. Fowler, J.J. Cunningham, N. Warner, R.J. Smeyne, F. Zindy, and S.X. Skapek The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development Proc. Natl. Acad. Sci. USA 99 2002 3848 3853
44. D. Michael, and M. Oren The p53-Mdm2 module and the ubiquitin system Semin. Cancer Biol. 13 2003 49 58
45. C.A. Midgley, J.M. Desterro, M.K. Saville, S. Howard, A. Sparks, R.T. Hay, and D.P. Lane An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo Oncogene 19 2000 2312 2323
46. M. Modestou, V. Puig-Antich, C. Korgaonkar, A. Eapen, and D.E. Quelle The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways Cancer Res. 61 2001 3145 3150
47. R. Montes de Oca Luna, D.S. Wagner, and G. Lozano Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 Nature 378 1995 203 206
48. K. Munger, and P.M. Howley Human papillomavirus immortalization and transformation functions Virus Res. 89 2002 213 228
49. A.Y. Nikolaev, M. Li, N. Puskas, J. Qin, and W. Gu Parc: a cytoplasmic anchor for p53 Cell 112 2003 29 40
50. G. Normand, P.G. Hemmati, B. Verdoodt, C. von Haefen, J. Wendt, D. Guner, E. May, B. Dorken, and P.T. Daniel p14ARF induces G2 cell cycle arrest in p53- and p21-deficient cells by down-regulating p34cdc2 kinase activity J. Biol. Chem. 280 2005 7118 7130
51. C.M. Pickart Mechanisms underlying ubiquitination Annu. Rev. Biochem. 70 2001 503 533
52. J. Pomerantz, N. Schreiber-Agus, N.J. Liegeois, A. Silverman, L. Alland, L. Chin, J. Potes, K. Chen, I. Orlow, and H.W. Lee The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53 Cell 92 1998 713 723
53. C. Prives, and P.A. Hall The p53 pathway J. Pathol. 187 1999 112 126
54. D.E. Quelle, F. Zindy, R.A. Ashmun, and C.J. Sherr Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest Cell 83 1995 993 1000
55. S. Rocha, K.J. Campbell, and N.D. Perkins p53- and Mdm2-independent repression of NF-κB transactivation by the ARF tumor suppressor Mol. Cell 12 2003 15 25
56. M. Scheffner, J.M. Huibregtse, R.D. Vierstra, and P.M. Howley The HPV- 16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 Cell 75 1993 495 505
57. N.E. Sharpless, and R.A. DePinho Telomerase, stem cells, senescence, and cancer J. Clin. Invest. 113 2004 160 168
58. C.J. Sherr The INK4a/ARF network in tumour suppression Nat. Rev. Mol. Cell Biol. 2 2001 731 737
59. T.R. Shirangi, A. Zaika, and U.M. Moll Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage FASEB J. 16 2002 420 422
60. J.M. Stommel, N.D. Marchenko, G.S. Jimenez, U.M. Moll, T.J. Hope, and G.M. Wahl A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking EMBO J. 18 1999 1660 1672
61. L.T. Vassilev, B.T. Vu, B. Graves, D. Carvajal, F. Podlaski, Z. Filipovic, N. Kong, U. Kammlott, C. Lukacs, and C. Klein In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 Science 303 2004 844 848
62. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
63. K.H. Vousden, and X. Lu Live or let die: the cell's response to p53 Nat. Rev. Cancer 2 2002 594 604
64. J.D. Weber, L.J. Taylor, M.F. Roussel, C.J. Sherr, and D. Bar-Sagi Nucleolar Arf sequesters Mdm2 and activates p53 Nat. Cell Biol. 1 1999 20 26
65. J.D. Weber, J.R. Jeffers, J.E. Rehg, D.H. Randle, G. Lozano, M.F. Roussel, C.J. Sherr, and G.P. Zambetti p53-independent functions of the p19(ARF) tumor suppressor Genes Dev. 14 2000 2358 2365
66. D.P. Xirodimas, C.W. Stephen, and D.P. Lane Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53 Exp. Cell Res. 270 2001 66 77
67. D. Xirodimas, M.K. Saville, C. Edling, D.P. Lane, and S. Lain Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo Oncogene 20 2001 4972 4983
68. W.G. Yarbrough, M. Bessho, A. Zanation, J.E. Bisi, and Y. Xiong Human tumor suppressor ARF impedes S-phase progression independent of p53 Cancer Res. 62 2002 1171 1177
69. Y. Zhang, Y. Xiong, and W.G. Yarbrough ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways Cell 92 1998 725 734